Evidence map›Paper›PMID 35742488›Full record

ArticleInternational journal of environmental research and public health2022

Concept for the Evaluation of Carcinogenic Substances in Population-Based Human Biomonitoring.

Klaus-Michael Wollin, Petra Apel, Yvonni Chovolou, Ulrike Pabel, Thomas Schettgen, Marike Kolossa-Gehring, Claudia Röhl, On Behalf Of The Human Biomonitoring Commission Of The German Environment Agency

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Klaus-Michael WollinFormerly Public Health Agency of Lower Saxony, 30449 Hannover, Germany.
Petra ApelGerman Environment Agency (UBA), 14195 Berlin, Germany.
Yvonni ChovolouNorth Rhine-Westphalia Office of Nature, Environment and Consumer Protection, 45659 Recklinghausen, Germany.ORCID 0000-0002-6324-0883
Ulrike PabelGerman Federal Institute for Risk Assessment (BfR), 10589 Berlin, Germany.
Thomas SchettgenInstitute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0003-1256-1713
Marike Kolossa-GehringGerman Environment Agency (UBA), 14195 Berlin, Germany.ORCID 0000-0001-8644-7564
Claudia RöhlDepartment of Environmental Health Protection, State Agency for social Services (LAsD) Schleswig-Holstein, 24534 Neumünster, Germany.ORCID 0000-0003-2798-2465
On Behalf Of The Human Biomonitoring Commission Of The German Environment Agency

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Human Biomonitoring (HBM) Commission at the German Environment Agency holds the opinion that for environmental carcinogens for which no exposure levels can be assumed and are harmless to health, health-based guidance values corresponding to the classical definition of the HBM-I or HBM-II value cannot be established. Therefore, only reference values have been derived so far for genotoxic carcinogens from exposure data of the general population or subpopulations. The concept presented here opens up the possibility of performing health risk assessments of carcinogenic substances in human biomonitoring, and thus goes decisively beyond the purely descriptive statistical reference value concept. Using the presented method, quantitative dose descriptors of internal exposure can be derived from those of external exposure, provided that sufficient toxicokinetic information is available. Dose descriptors of internal exposure then allow the simple estimate of additional lifetime cancer risks for measured biomarker concentrations or, conversely, of equivalent concentrations for selected risks, such as those considered as tolerable for the general population. HBM data of chronic exposures to genotoxic carcinogens can thus be used to assess the additional lifetime cancer risk referring to the general population and to justify and prioritize risk management measures.

Indexed as

Carcinogens, EnvironmentalEnvironmental PollutantsBiological MonitoringEnvironmental ExposureEnvironmental MonitoringHumansReference ValuesRisk AssessmentCarcinogens, EnvironmentalEnvironmental Pollutantscarcinogenshuman biomonitoringinternal exposurerisk assessment

Identifiers

PMID35742488
PMCPMC9223427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.